294 related articles for article (PubMed ID: 18502572)
1. Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia.
Hong CC; Lay JD; Huang JS; Cheng AL; Tang JL; Lin MT; Lai GM; Chuang SE
Cancer Lett; 2008 Sep; 268(2):314-24. PubMed ID: 18502572
[TBL] [Abstract][Full Text] [Related]
2. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt.
Melaragno MG; Cavet ME; Yan C; Tai LK; Jin ZG; Haendeler J; Berk BC
J Mol Cell Cardiol; 2004 Oct; 37(4):881-7. PubMed ID: 15380678
[TBL] [Abstract][Full Text] [Related]
3. Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells.
Hasanbasic I; Cuerquis J; Varnum B; Blostein MD
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1207-13. PubMed ID: 15130893
[TBL] [Abstract][Full Text] [Related]
4. Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma.
Ben-Batalla I; Schultze A; Wroblewski M; Erdmann R; Heuser M; Waizenegger JS; Riecken K; Binder M; Schewe D; Sawall S; Witzke V; Cubas-Cordova M; Janning M; Wellbrock J; Fehse B; Hagel C; Krauter J; Ganser A; Lorens JB; Fiedler W; Carmeliet P; Pantel K; Bokemeyer C; Loges S
Blood; 2013 Oct; 122(14):2443-52. PubMed ID: 23982172
[TBL] [Abstract][Full Text] [Related]
5. The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development.
Park IK; Giovenzana C; Hughes TL; Yu J; Trotta R; Caligiuri MA
Blood; 2009 Mar; 113(11):2470-7. PubMed ID: 18840707
[TBL] [Abstract][Full Text] [Related]
6. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
Gioia R; Trégoat C; Dumas PY; Lagarde V; Prouzet-Mauléon V; Desplat V; Sirvent A; Praloran V; Lippert E; Villacreces A; Leconet W; Robert B; Vigon I; Roche S; Mahon FX; Pasquet JM
J Pathol; 2015 Sep; 237(1):14-24. PubMed ID: 25965880
[TBL] [Abstract][Full Text] [Related]
7. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway.
Sawabu T; Seno H; Kawashima T; Fukuda A; Uenoyama Y; Kawada M; Kanda N; Sekikawa A; Fukui H; Yanagita M; Yoshibayashi H; Satoh S; Sakai Y; Nakano T; Chiba T
Mol Carcinog; 2007 Feb; 46(2):155-64. PubMed ID: 17186543
[TBL] [Abstract][Full Text] [Related]
8. GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance.
Baumann C; Ullrich A; Torka R
Mol Oncol; 2017 Oct; 11(10):1430-1447. PubMed ID: 28675785
[TBL] [Abstract][Full Text] [Related]
9. Noninsulin-dependent diabetes mellitus occurs in mice ectopically expressing the human Axl tyrosine kinase receptor.
Augustine KA; Rossi RM; Van G; Housman J; Stark K; Danilenko D; Varnum B; Medlock E
J Cell Physiol; 1999 Dec; 181(3):433-47. PubMed ID: 10528229
[TBL] [Abstract][Full Text] [Related]
10. Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase.
Fridell YW; Jin Y; Quilliam LA; Burchert A; McCloskey P; Spizz G; Varnum B; Der C; Liu ET
Mol Cell Biol; 1996 Jan; 16(1):135-45. PubMed ID: 8524290
[TBL] [Abstract][Full Text] [Related]
11. Axl inhibition: a potential road to a novel acute myeloid leukemia therapy?
Janning M; Ben-Batalla I; Loges S
Expert Rev Hematol; 2015 Apr; 8(2):135-8. PubMed ID: 25578023
[TBL] [Abstract][Full Text] [Related]
12. Adhesion-related kinase induction of migration requires phosphatidylinositol-3-kinase and ras stimulation of rac activity in immortalized gonadotropin-releasing hormone neuronal cells.
Nielsen-Preiss SM; Allen MP; Xu M; Linseman DA; Pawlowski JE; Bouchard RJ; Varnum BC; Heidenreich KA; Wierman ME
Endocrinology; 2007 Jun; 148(6):2806-14. PubMed ID: 17332061
[TBL] [Abstract][Full Text] [Related]
13. Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around chernobyl.
Ito M; Nakashima M; Nakayama T; Ohtsuru A; Nagayama Y; Takamura N; Demedchik EP; Sekine I; Yamashita S
Thyroid; 2002 Nov; 12(11):971-5. PubMed ID: 12490074
[TBL] [Abstract][Full Text] [Related]
14. Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway.
Scutera S; Fraone T; Musso T; Cappello P; Rossi S; Pierobon D; Orinska Z; Paus R; Bulfone-Paus S; Giovarelli M
J Immunol; 2009 Sep; 183(5):3004-13. PubMed ID: 19657094
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor.
Gallicchio M; Mitola S; Valdembri D; Fantozzi R; Varnum B; Avanzi GC; Bussolino F
Blood; 2005 Mar; 105(5):1970-6. PubMed ID: 15507525
[TBL] [Abstract][Full Text] [Related]
16. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis.
Neubauer A; Fiebeler A; Graham DK; O'Bryan JP; Schmidt CA; Barckow P; Serke S; Siegert W; Snodgrass HR; Huhn D
Blood; 1994 Sep; 84(6):1931-41. PubMed ID: 7521695
[TBL] [Abstract][Full Text] [Related]
17. Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia.
Park IK; Mundy-Bosse B; Whitman SP; Zhang X; Warner SL; Bearss DJ; Blum W; Marcucci G; Caligiuri MA
Leukemia; 2015 Dec; 29(12):2382-9. PubMed ID: 26172401
[TBL] [Abstract][Full Text] [Related]
18. The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology.
Yanagita M
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):465-70. PubMed ID: 15199298
[TBL] [Abstract][Full Text] [Related]
19. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis.
Yanagita M; Arai H; Ishii K; Nakano T; Ohashi K; Mizuno K; Varnum B; Fukatsu A; Doi T; Kita T
Am J Pathol; 2001 Apr; 158(4):1423-32. PubMed ID: 11290560
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib
Dumas PY; Naudin C; Martin-Lannerée S; Izac B; Casetti L; Mansier O; Rousseau B; Artus A; Dufossée M; Giese A; Dubus P; Pigneux A; Praloran V; Bidet A; Villacreces A; Guitart A; Milpied N; Kosmider O; Vigon I; Desplat V; Dusanter-Fourt I; Pasquet JM
Haematologica; 2019 Oct; 104(10):2017-2027. PubMed ID: 30923103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
